NSE: ALKEM · Healthcare · Pharmaceuticals · Market cap ₹63,417 Cr
· Prev close ₹5,297.00 · 52W ₹4,811–5,934
Day range for 8 Nov not in the price history yet · 6 Nov ₹5,141.00–5,297.00
Last 4 quarters: profit −6.7% on the 4 beforeShare price +0.1% in a month12 Nov Sep-quarter results
If profit compounds at 8.2% (CAGR) and the stock ends at 25×, buying at ₹5,304 returns about 6.5% CAGR over 10 years.
| Growth assumption | Profit growth (CAGR) | Return, 10Y CAGR |
|---|---|---|
| Yours | 8.2% | 6.5% |
| Delivered FY22–26 | 8.2% | 6.5% |
| Net profit, last 4 quarters vs the 4 before | −6.7% | −8.2% |
| Half the delivered pace | 4.1% | 2.4% |
Delivered FY22–26 CAGR 8.2%
This is an exit-multiple calculation, not a discounted cash flow. Inputs: , price ₹5,304.00 (8 Nov 2026, 3:59 pm IST price). Formula: return = (EPS × exit P/E ÷ price)^(1/10) × (1 + growth) − 1. Net profit growth is applied to EPS, so the share count is held constant. A profit fall of 100% or more has no rate and is left blank. Dividends ignored. Arithmetic, not a forecast.